Downregulation of heme oxygenase 1 (HO-1) activity in hematopoietic cells enhances their engraftment after transplantation

Cell Transplantation

Volumn 25, Issue 7, 2016, Pages 1265-1276

  Adamiak, Mateusz ^a   Moore, Joseph B ^b   Zhao, John ^b   Abdelbaset Ismail, Ahmed ^a   Grubczak, Kamil ^c   Rzeszotek, Sylwia ^a,d   Wysoczynski, Marcin ^b   Ratajczak, Mariusz Z ^a,e  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adhesion; Chemotaxis; Hematopoietic recovery; Heme oxygenase 1 (HO 1); Sphingosine 1 phosphate (S1P); Stem cell homing; Stromal derived factor 1 (SDF 1)

Indexed keywords

HEME OXYGENASE 1; SPHINGOSINE 1 PHOSPHATE; STROMAL CELL DERIVED FACTOR 1; ENZYME INHIBITOR; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL; CELL COUNT; CELL LINE; CELL MIGRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; ENGRAFTMENT; ENZYME ACTIVITY; ENZYME INHIBITION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD CELL COUNT; C57BL MOUSE; CELL ADHESION; CHEMOTAXIS; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KNOCKOUT MOUSE; METABOLISM; TUMOR CELL LINE;

ANIMALS; BLOOD CELL COUNT; CELL ADHESION; CELL LINE, TUMOR; CHEMOKINE CXCL12; CHEMOTAXIS; DOWN-REGULATION; ENZYME INHIBITORS; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HEME OXYGENASE-1; HUMANS; LYSOPHOSPHOLIPIDS; MICE, INBRED C57BL; MICE, KNOCKOUT; SPHINGOSINE;

EID: 84978120479     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X688957     Document Type: Article

References (37)

1. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity 2003; 19: 257-67.
2. Nagasawa T. A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis. Int J Hematol. 2000; 72 (4): 408-11.
3. Lapidot T, Kollet O. The brain-bone-blood triad: Traffic lights for stem-cell homing and mobilization. Hematology Am Soc Hematol Educ Program 2010; 2010: 1-6.
4. Bonig H, Papayannopoulou T. Hematopoietic stem cell mobilization: Updated conceptual renditions. Leukemia 2013; 27 (1): 24-31.
5. Lévesque JP, Helwani FM, Winkler IG. The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 2010; 24 (12): 1979-92.
6. Doan PL, Chute JP. The vascular niche: Home for normal and malignant hematopoietic stem cells. Leukemia 2012; 26 (1): 54-62.
7. Ratajczak MZ. A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking. Leukemia 2015; 29 (4): 776-82.
8. Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, Moseman EA, Huff IV, Junt T, Wagers AJ, Mazo IB, von Andrian UH. Physiological recirculation of hematopoietic stem and progenitor cells through blood, lymph and extramedullary tissues. Cell 2007; 131 (5): 994-1008.
9. Seitz G, Boehmler AM, Kanz L, Möhle R. The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cells. Ann NY Acad Sci. 2005; 1044: 84-9.
10. Ratajczak MZ, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin MJ, Kucia M, Janowska-Wieczorek A, Ratajczak J. Novel insight into stem cell mobilization—Plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/ membrane attack complex. Leukemia 2010; 24 (5): 976-85.
11. Kim CH, Wu W, Wysoczynski M, Abdel-Latif A, Sunkara M, Morris A, Kucia M, Ratajczak J, Ratajczak MZ. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: A novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 2012; 26 (1): 106-16.
12. Arana L, Gangoiti P, Ouro A, Trueba M, Gámez-Mũoz A. Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis. 2010; 9: 15.
13. Ratajczak MZ, Kim CH, Abdel-Latif A, Schneider G, Kucia M, Morris AJ, Laughlin MJ, Ratajczak J. A novel perspective on stem cell homing and mobilization: Review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 2012; 26 (1): 63-72.
14. Ratajczak MZ, Reca R, Wysoczynski M, Kucia M, Baran JT, Allendorf DJ, Ratajczak J, Ross GD. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia 2004; 18 (9): 1482-90.
15. Lee HM, Wu W, Wysoczynski M, Liu R, Zuba-Surma EK, Kucia M, Ratajczak J, Ratajczak MZ. Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 2009; 23 (11): 2052-62.
16. Wu W, Kim CH, Liu R, Kucia M, Marlicz W, Greco N, Ratajczak J, Laughlin MJ, Ratajczak MZ. The bone marrowexpressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Leukemia 2012; 26 (4): 736-45.
17. Hoggatt J, Pelus LM. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia 2010; 24 (12): 1993-2002.
18. Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S, Kollet O, Hershkoviz R, Alon R, Hardan I, Ben-Hur H, Naor D, Nagler A, Lapidot T. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004; 103 (8): 2981-9.
19. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol. 2010; 80 (12): 1895-903.
20. Cao YA, Wagers AJ, Karsunky H, Zhao H, Reeves R, Wong RJ, Stevenson DK, Weissman IL, Contag CH. Heme oxygenase-1 deficiency leads to disrupted response to acute stress in stem cells and progenitors. Blood 2008; 112 (12): 4494-502.
21. Kawashima A, Oda Y, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol. 2002; 33 (1): 125-30.
22. Freitas A, Alves-Filho JC, Secco DD, Neto AF, Ferreira SH, Barja-Fidalgo C, Cunha FQ. Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol. 2006; 149 (4): 345-54.
23. Wysoczynski M, Ratajczak J, Pedziwiatr D, Rokosh G, Bolli R, Ratajczak MZ. Identification of heme oxygenase 1 (HO-1) as a novel negative regulator of mobilization of hematopoietic stem/progenitor cells. Stem Cell Rev. 2015; 11 (1): 110-8.
24. Ratajczak MZ, Borkowska S, Mierzejewska K, Kucia M, Mendek-Czajkowska E, Suszynska M, Sharma VA, Deptala A, Song W, Platzbecker U, Larratt L, Janowska-Wieczorek A, Maciejewski J, Ratajczak J. Further evidence that paroxysmal nocturnal haemoglobinuria is a disorder of defective cell membrane lipid rafts. J Cell Mol Med. 2015; 19 (9): 2193-201.
25. Wysoczynski M, Reca R, Lee H, Wu W, Ratajczak J, Ratajczak MZ. Defective engraftment of C3aR-/-hematopoietic stem progenitor cells reveals a novel role of the C3a-C3aR axis in bone marrow homing. Leukemia 2009; 23 (8): 1455-61.
26. Castello S, Podestà M, Menditto VG, Ibatici A, Pitto A, Figari O, Scarpati D, Magrassi L, Bacigalupo A, Piaggio G, Frassoni F. Intra-bone marrow injection of bone marrow and cord blood cells: An alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol. 2004; 32 (8): 782-7.
27. Lemoli RM, Ferrari D, Fogli M, Rossi L, Pizzirani C, Forchap S, Chiozzi P, Vaselli D, Bertolini F, Foutz T, Aluigi M, Baccarani M, Di Virgilio F. Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 2004; 104 (6): 1662-70.
28. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R, Salati S, Salvestrini V, Gulinelli S, Adinolfi E, Ferrari S, Di Virgilio F, Baccarani M, Lemoli RM. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 2007; 109 (2): 533-42.
29. Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305 (5686): 1000-3.
30. Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW. CD26 inhibition enhances allogeneic donorcell homing and engraftment after in utero hematopoieticcell transplantation. Blood 2006; 108 (13): 4268-74.
31. Myers J, Huang Y, Wei L, Yan Q, Huang A, Zhou L. Fucosedeficient hematopoietic stem cells have decreased selfrenewal and aberrant marrow niche occupancy. Transfusion 2010; 50 (12): 2660-9.
32. Sackstein R. Glycoengineering of HCELL, the human bone marrow homing receptor: Sweetly programming cell migration. Ann Biomed Eng. 2012; 40 (4): 766-76.
33. Dolnikov A, Xu N, Shen S, Song E, Holmes T, Klamer G, O’Brien TA. GSK-3b inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells. Cell Prolif. 2014; 47 (2): 113-23.
34. Goichberg P, Kalinkovich A, Borodovsky N, Tesio M, Petit I, Nagler A, Hardan I, Lapidot T. cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors. Blood 2006; 107 (3): 870-9.
35. Kinderlerer AR, Pombo Gregoire I, Hamdulay SS, Ali F, Steinberg R, Silva G, Ali N, Wang B, Haskard DO, Soares MP, Mason JC. Heme oxygenase-1 expression enhances vascular endothelial resistance to complementmediated injury through induction of decay-accelerating factor: A role for increased bilirubin and ferritin. Blood 2009; 113 (7): 1598-607.
36. Lund TC, Boitano AE, Delaney CS, Shpall EJ, Wagner JE. Advances in umbilical cord blood manipulation—From niche to bedside. Nat Rev Clin Oncol. 2015; 12 (3): 163-74.
37. Pineault N, Abu-Khader A. Advances in umbilical cord blood stem cell expansion and clinical translation. Exp Hematol. 2015; 43 (7): 498-513.